Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy 10X Genomics stock
Learn how to easily invest in 10X Genomics stock.
10X Genomics is a health information services business based in the US. 10X Genomics shares (TXG) are listed on the NASDAQ and all prices are listed in US Dollars. 10X Genomics employs 1,243 staff and has a trailing 12-month revenue of around $516.4 million.
How to buy 10X Genomics stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – TXG. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
- Easy to use platform with $0 stock trading & no annual fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+
10X Genomics stock price (NASDAQ: TXG)Use our graph to track the performance of TXG stocks over time.
10X Genomics shares at a glance
|Latest market close||$48.13|
|52-week range||$23.81 - $83.34|
|50-day moving average||$45.87|
|200-day moving average||$39.06|
|Wall St. target price||$51.70|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-1.51|
Buy 10X Genomics stocks from these online trading platformsCompare special offers, low fees and a wide range of investment options among top trading platforms.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy 10X Genomics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
10X Genomics price performance over time
Historical closes compared with the close of $48.13 from 2023-03-17
|1 week (2023-03-14)||-1.11%|
|1 month (2023-02-21)||0.06%|
|3 months (2022-12-21)||30.29%|
|6 months (2022-09-21)||59.21%|
|1 year (2022-03-17)||-28.22%|
|2 years (2021-03-19)||-72.92%|
|3 years (2020-03-20)||55.78|
|5 years (2018-03-17)||N/A|
10X Genomics financials
|Revenue TTM||$516.4 million|
|Gross profit TTM||$396 million|
|Return on assets TTM||-10.25%|
|Return on equity TTM||-20.45%|
|Market capitalisation||$5.6 billion|
TTM: trailing 12 months
10X Genomics share dividends
We're not expecting 10X Genomics to pay a dividend over the next 12 months.
Have 10X Genomics's shares ever split?
10X Genomics's shares were split on a 1:2 basis on 16 July 2006. So if you had owned 2 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your 10X Genomics shares – just the quantity. However, indirectly, the new 100% higher share price could have impacted the market appetite for 10X Genomics shares which in turn could have impacted 10X Genomics's share price.
10X Genomics share price volatility
Over the last 12 months, 10X Genomics's shares have ranged in value from as little as $23.81 up to $83.34. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while 10X Genomics's is 1.731. This would suggest that 10X Genomics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
10X Genomics overview
10x Genomics, Inc. , a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell Assay for Transposase Accessible Chromati (ATAC) for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc.
10X Genomics in the news
NextGen (NXGN) Riding on the Success of Cloud-Based Solution
We're Hopeful That 10x Genomics (NASDAQ:TXG) Will Use Its Cash Wisely
10x Genomics to Present at the 43rd Annual Cowen Healthcare Conference
Frequently asked questionsWhat percentage of 10X Genomics is owned by insiders or institutions?
Currently 2.581% of 10X Genomics shares are held by insiders and 99.974% by institutions. How many people work for 10X Genomics?
Latest data suggests 1,243 work at 10X Genomics. When does the fiscal year end for 10X Genomics?
10X Genomics's fiscal year ends in December. Where is 10X Genomics based?
10X Genomics's address is: 6230 Stoneridge Mall Road, Pleasanton, CA, United States, 94588-3260 What is 10X Genomics's ISIN number?
10X Genomics's international securities identification number is: US88025U1097 What is 10X Genomics's CUSIP number?
10X Genomics's Committee on Uniform Securities Identification Procedures number is: 88025U109
More guides on Finder
How to Buy Treasury Bills
Treasury Bills are fixed-income assets with maturities of less than one year. Here’s what to know before investing.
How to buy Vanguard VTI Total Stock Market ETF units
Steps to investing in the Vanguard (VTI) Total Stock Market ETF.
How to buy Neuraxis (NRXS) stock when it goes public
Everything we know about the Neuraxis IPO, plus information on how to buy in.
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
Ask an Expert